LFB

Serial Number 79220430
Registration 5557831
707

Registration Progress

Application Filed
Aug 29, 2017
Under Examination
Approved for Publication
Jun 26, 2018
Published for Opposition
Jun 26, 2018
Registered
Sep 11, 2018

Trademark Image

LFB

Basic Information

Serial Number
79220430
Registration Number
5557831
Filing Date
August 29, 2017
Registration Date
September 11, 2018
Published for Opposition
June 26, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
707
Status Date
Feb 19, 2025
Registration
Registered
Classes
005 009 042 044

Rights Holder

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

33
Address
3 avenue des Tropiques
LES ULIS F-91940
FR

Ownership History

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

Original Applicant
33
F-91940 LES ULIS FR

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

Owner at Publication
33
F-91940 LES ULIS FR

LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

Original Registrant
33
LES ULIS FR

Legal Representation

Attorney
James R. Davis, II

USPTO Deadlines

Next Deadline
1134 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2018-09-11)
Due Date
September 11, 2028
Grace Period Ends
March 11, 2029

Application History

37 events
Date Code Type Description Documents
May 20, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 20, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 20, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
May 20, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 20, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 19, 2025 NA71 E NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED Loading...
Feb 19, 2025 71.P O REGISTERED - PARTIAL SEC 71 ACCEPTED Loading...
Feb 18, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Sep 3, 2024 ES71 I TEAS SECTION 71 RECEIVED Loading...
May 4, 2024 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Sep 11, 2023 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
Apr 15, 2021 CORN I CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Loading...
Apr 9, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 3, 2021 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB Loading...
Mar 5, 2021 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Mar 15, 2019 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Dec 19, 2018 XXSS O GENERIC MADRID TRANSACTION SENT TO IB Loading...
Dec 19, 2018 XXCR P GENERIC MADRID TRANSACTION CREATED Loading...
Dec 11, 2018 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Sep 11, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 26, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 26, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jun 6, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 21, 2018 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 19, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 19, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 16, 2018 ALIE A ASSIGNED TO LIE Loading...
May 9, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 19, 2018 RFNT P REFUSAL PROCESSED BY IB Loading...
Dec 17, 2017 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Dec 17, 2017 RFRR P REFUSAL PROCESSED BY MPU Loading...
Dec 7, 2017 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Dec 6, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 4, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 21, 2017 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 15, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 9, 2017 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical and veterinary products and preparations for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care; medicines for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care [ ; diagnostic products for medical and veterinary use for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care ]
Class 009
[ Scientific apparatus and instruments, namely, diagnostic apparatus and instruments for calculating and managing drug penetration parameters, for assessing immune deficiency, for laboratory use; downloadable electronic and digital publications, namely, magazines, newsletters, brochures, articles in the field of health; ] downloadable instructional and teaching material, namely, software in the field of health; [ electronic reports featuring results from clinical trials and studies in the field of health; ] recorded software, namely, software for providing medical information in the field of immunology, haemostasis, intensive care, immune deficiency; computer software for educational and commercial activities, namely, software providing information in the field of health; software applications used with medical diagnostic apparatus to calculate and manage immune deficiency or bleeding; computer software for Websites, Intranet and the Internet, namely, software for training and information of patients and health professionals; downloadable computer software applications in the field of health for calculating and managing drug penetration parameters in the human body
Class 042
[ Scientific and technological services as well as research and design services relating thereto, namely, scientific research, product development, design and testing for new product and engineering in the field of health; industrial analysis and research services in the field of health; scientific research services using protein expression platform technology for research and development of pharmaceuticals; scientific research services using protein expression platform technology for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines; conducting scientific studies in the field of immunology, haemostasis, intensive care; research and development of new products for others; scientific research for medical purposes in the field of immunology, haemostasis, intensive care; cellular and molecular biology research; testing of pharmaceutical products; conducting clinical trials for others in the field of immunology, haemostasis, intensive care; engineering; ] advice and assistance in the field of health
Class 044
[ Medical analysis relating to human blood plasma; ] sampling, collection and preservation of human blood plasma; providing advice and information in the field of health

Classification

International Classes
005 009 042 044